Hikma Pharmaceuticals PLC HIK shares slipped 1.81% to £19.56 Friday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.73% to ...
Azurity Pharmaceuticals’ Nymalize (nimodipine) oral solution in a 30mg/5ml prefilled ENFit syringe has received US Food and Drug Administration (FDA) approval. The ready-to-use prefilled syringe ...
India's fourth largest pharma company is taking a big leap with a costly acquisition which many think needs to be watched. But Ramesh C Juneja and Rajeev Juneja, who cofounded Mankind, think the ...
The Nymalize prefilled ENFit syringe will be available to order through a pharmaceutical wholesaler in the coming weeks. For important safety information and full prescribing information ...
(RTTNews) - Arrowhead Pharmaceuticals (ARWR) reported results from the Phase 3 PALISADE study of investigational plozasiran in patients with familial chylomicronemia syndrome. The company said ...
Barclays cuts Prudential price target to 1,250 (1,380) pence - 'overweight' Barclays reinitiates Barratt Developments with 'overweight' - price target 641 pence Barclays raises HGCapital Trust to ...
Recursion Pharmaceuticals Inc RXRX shares are trading lower. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback